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a b s t r a c t
We report a RNA species of 429 nucleotides derived from the 3′ untranslated region of the viral genome
in Dengue 2 virus (DENV-2) infected cells. The 3′ terminal of viral RNA contained speciﬁc conserved
structures that are important for the production of subgenomic RNA. Transient replicon assays suggested
that loss of this small RNA has little effect on viral replication, and genetic analysis using recombinant
viruses demonstrated that the existence of this subgenomic RNA is not essential for the life cycle of the
DENV-2. Results from cytotoxicity and apoptosis assay revealed that the generation of subgenomic RNA
is signiﬁcant for DENV-2 viral cytopathicity and virus-induced apoptosis; and the deﬁciency could
be partially restored by providing subgenomic RNA in trans from transfection. In addition, we found that
subgenomic RNA modulates the phosphatidylinositol 3-kinase (PI3k)/Akt signaling pathway through a
Bcl-2-related mechanism, resulting in apoptotic cell death.
& 2013 Elsevier Inc. All rights reserved.
Introduction
The Flaviviridae family comprises three genera: Flavivirus, Pesti-
virus and Hepacivirus. Most of the ﬂaviviruses are arthropod-borne
viruses and mainly transmitted to vertebrate hosts by either
mosquitoes or ticks (Gubler et al., 2007). Dengue virus (DENV)
belongs to the Flavivirus genus and causes potentially fatal diseases
in humans and animals. Annually about 50 to 100 million people in
the world suffer from dengue fever, including 500 thousand cases of
dengue hemorrhagic fever and dengue shock syndrome (Kyle and
Harris, 2008). Besides four serotypes of DENV, several members of
ﬂaviviruses, such as West Nile virus (WNV), yellow fever virus (YFV),
Japanese Encephalitis virus (JEV), and tick-borne encephalitis virus
(TBEV), also are major human pathogens (Gould and Solomon, 2008).
Currently, no effective antiviral therapy for ﬂavivirus infection is
available.
DENV is an enveloped virus with a single-stranded, positive-
sense RNA genome about 11 kb in length. The viral RNA consists
of one open reading frame (ORF) ﬂanked by highly structured 5′
and 3′ untranslated regions (UTRs) (Gubler et al., 2007). The single
open reading frame encodes ten viral proteins required for the
viral life cycle, including three structural proteins [capsid (C)-
premembrane (prM)-envelope (E)] and seven non-structural
proteins (in the order NS1-NS2A-NS2B-NS3-NS4A-NS4B-NS5)
(Lindenbach et al., 2007; Rice et al., 1985). The structural proteins
form viral particles and mediate virus entry, while the nonstruc-
tural proteins participate in viral replication, virion assembly
(Kummerer and Rice, 2002; Liu et al., 2003) and invasion of innate
immune response (Guo et al., 2005; Munoz-Jordan et al., 2003).
The conserved nucleotide sequence and secondary structure in the
UTRs of DENV serve various functions in viral translation, RNA
replication, and encapsidation (Markoff, 2003). The DENV 5′ UTR
contains two RNA secondary structures, a large stem-loop (SLA)
and a short stem-loop (SLB) (Gebhard et al., 2011). The SLA and SLB
structures have been shown to be necessary for viral RNA synth-
esis (Alvarez et al., 2005; Filomatori et al., 2006; Yu et al., 2008).
Speciﬁc structures at the 3′ end of the viral genome also serve
crucial roles in replication, especially the terminal stem-loop
structure (3′ SL) (Zeng et al., 1998). The importance of 3′ SL for
DENV and other ﬂaviviruses is supported by a variety of experi-
mental evidence (Brinton et al., 1986; Hahn et al., 1987; Yu and
Markoff, 2005; Zeng et al., 1998).
Apart from the genome RNA (gRNA), a mass of subgenomic
RNA (sgRNA) derived from the 3′ UTR is found in infected cells
with Murray Valley encephalitis (MVE), JEV, WNV, and DENV (Liu
et al., 2010). The small noncoding RNA is a unique characteristic of
the Flavivirus genus, and possibly has a signiﬁcant effect on virus–
host interaction in the viral life cycle. In WNV and YFV it has been
demonstrated that the accumulation of sgRNA is a product of
incomplete degradation of viral genome RNA by exoribonuclease
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XRN1. Additionally, sgRNA in WNV is essential for viral cytopathi-
city in cells and pathogenicity in mice (Pijlman et al., 2008; Silva
et al., 2010). Some secondary structures and RNA pseudoknot
interactions in 3′ UTR are required for ﬂaviviral sgRNA generation
(Funk et al., 2010; Yang et al., 2002). Furthermore it has been
proved that sgRNA contributes to WNV evasion of the type I
interferon-mediated antiviral response (Schuessler et al., 2012)
and other research reveals sgRNA may modulate JEV translation
and replication (Fan et al., 2011). More recently, a study has
demonstrated that sgRNA displays as a nucleic acid-based reg-
ulator of RNAi pathways in WNV (Schnettler et al., 2012). However,
the mechanism of this small sgRNA production and its function in
DENV lifecycle remains unknown.
Apoptosis has been observed as a result of ﬂavivirus infection
(Despres et al., 1996) since host cells are thought to activate
biochemically distinct apoptotic pathways when they encounter
a ﬂavivirus. In the JEV-induced apoptosis endoplasmic reticulum
(ER) stress might participate, triggering p38 MAPK activation and
CHOP induction (Su et al., 2002). Thus, cells infected with WNV
can cause caspase-3 and -9 activations through the mitochondrial
pathway (Chu and Ng, 2003). Growing evidence shows that
Dengue virus infection will trigger apoptotic cell death in vitro
and in vivo in a cell-dependent manner. Although many intracel-
lular signaling systems are involved in the induction of apoptosis
in Dengue virus infected cells, the underlying molecular processes
are not well characterized (Courageot et al., 2003).
In this paper, we report a RNA species present in DENV-2-
infected cells. Northern blot showed that kinetics of sgRNA appear-
ance paralleled that of DENV-2 genome. Using primer extension
we determined the sgRNA was 429 nt in length and corresponded
to the 3′ terminus of the genome. Mutagenesis studies proved that
some conserved motifs in region II of 3′ UTR were crucial for sgRNA
generation. Combining the results from DENV-2 replicons and
infectious cDNA clones, we concluded that sgRNA had little effect
on viral life cycle, but demonstrated sgRNA production was neces-
sary for viral cytopathicity in cell culture. Furthermore we eluci-
dated a novel role for sgRNA as a determinant in DENV-2 virus-
induced apoptosis pathway. The data is important for further study
of the DENV life cycle and virus–host interaction, as well as for the
therapeutical treatment of DENV infection.
Results
Identiﬁcation of subgenomic RNA in DENV-2
Northern hybridization with the corresponding 3′ UTR-speciﬁc
probe showed that Vero cells infected with DENV-2 (TSV01 strain)
produced a subgenomic RNA (sgRNA) of about 400 nucleotides (nt)
in size (Fig. 1A—Lane VERO). Total RNA was extracted from the
mammalian cells at 48 h post infection (p.i.), and were analyzed
using a DIG-labeled oligonucleotide, complementary to nt 10,622 to
nt 10,723 in the DENV-2 3′ UTR as a probe. In addition, experiment
with viral RNA extracted from DENV-2 showed that sgRNA was not
packaged into mature dengue virions (Fig. 1A—Lane DEN-2). On the
basis of sgRNA estimated length, we assumed its 5′ initiation would
be located in the viral 3′ UTR. Primer extension of a 5′-biotinylated
oligonucleotide, complementary to DENV-2 nt 10,360 to nt 10,384
and sequence analysis revealed that the 5′ end of the DENV-2
sgRNA was residue A at position 10,295 (Fig. 1C). Combined with
the genome size of DENV-2 we determined the length of DENV-2
sgRNA was 429 nt. In order to elucidate the mechanism of sgRNA
generation, we examined whether the structural proteins or viral
replication were involved. We electroporated BHK-21 cells with
DENV-2 nonreplicating replicon RNA and DENV-2 wild type repli-
con RNA, at the same time we transfected pSUPER-3′ UTR vector
with liposome and extracted the total RNAs. In experiments with
dengue replicon RNA and pSUPER-3′ UTR vector, we clearly found
that sgRNA could be easily detected in cells transfected with all
constructs (Fig. 1B), replicating (DEN-2 Rep) or nonreplicating (Rep-
NS5 Mut), thus clarifying that viral proteins and RNA replication
were dispensable for sgRNA production. The replication defective
RNA was designed by replacing the essential GDD motif of the
RNA dependent RNA polymerase NS5 by AAA (DVRep-NS5Mut)
(Khromykh et al., 1998).
Time course study of sgRNA and viral genome yield in DENV-2
infected cells
To determine the kinetics of appearance of the sgRNA and
genomic RNA (gRNA), BHK-21 and Vero cells were infected with
DENV-2 at a multiplicity of infection (MOI) of 0.5. Then total RNAs
were isolated at the indicated times post-infection and analyzed by
Northern Blot. The result showed that both gRNA and sgRNA can be
detected up to 48 h post infection in two cell types. Throughout the
experiment, the abundance of sgRNA continued to increase and was
obviously much greater than that of gRNA (according to the size and
densities of the bands) (Fig. 2A and B).
RNA structure/sequence requirements for sgRNA generation
The 451 nt long DENV-2 (TSV01 strain) 3′ UTR can be divided
into three regions (Fig. 3A). These harbored a number of speciﬁc
structures which played important roles, including structure X at
the 5′ end, conserved (repeated) sequences (CS2 and RCS2), top
loop of hairpins (TL1/2), a cyclization sequence and a conserved
stem-loop structure at the 3′ end (3′ LSH) (Ramanathan et al.,
2006). To investigate the RNA structures responsible for sgRNA
generation, we constructed a series of deletion mutations in the 3′
UTR (Fig. 3B) and tested their effect on sgRNA production in
infected cells (Fig. 3C). Northern blot analysis indicated that
deletions in AU-rich region (M1), structure X (M2), TL1 (M3),
RCS2 (M4), TL2 (M5), CS2 (M6), and region I (M7) did not affect
sgRNA production, and M3 and M4 viruses produced less abun-
dance of sgRNA than the others. Most importantly, only the
deletion in region II (M8) led to the total loss of sgRNA.
SgRNA production is not required for the life cycle of DENV-2
For studying the effect of the full length and amount of sgRNA
on viral life, BHK-21 cells were transfected with equal amounts
of replicon RNAs of the wild type (WT) and the mutants, and the
luciferase activities at various time post transfection were recorded.
By using a DENV-2 transient replicon assay, RNA translation and
ampliﬁcation could be assayed through the expression of luciferase
at 6 h and 60 h after transfection. As shown in the ﬁgure (Fig. 4A–C),
all mutations did not affect the translation of input RNA. Except
for DVRep-NS5Mut, which was a replication defective mutation,
other mutant replicons maintained almost the same level of
luciferase signals as the wild type after 24 h post transfection. We
then assessed their corresponding E protein expression and growth
in mammalian cells. At 96 h post infection wild type and recombi-
nant viruses all expressed E protein normally using IFA (Fig. 4D).
Growth kinetics among wild type and the mutants exhibited slight
differences (Fig. 4E). Mutations including M1, M2, M5–M7 almost
kept pace with WT in viral lifecycle, while viral titers in M3 and M4
were lower than that of WT. Mutation M8 showed a slight delay in
initial virus production compared to the WT, so its lifecycle lagged a
little. Collectively, mutations (including M1–M8) did not have a
major effect on viral translation, replication, E protein expression or
viral lifecycle. But generation of abundant full-length sgRNA made
the virus more effective.
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SgRNA production is of signiﬁcant importance for viral cytopathicity
in cell culture
In order to illuminate the function of sgRNA, we ﬁrst compared
plaque morphology between wild type and recombinant viruses
by SIA (Fig. 5A). The results indicated that for the following
mutations abolishing sgRNA production (M8) showed no visible
plaque formation, and lower abundance of sgRNA production
mutants (M3 and M4) showed vague plaque formation. The rest
of the mutations and the wild type formed clear and visible
plaques. In addition we performed plaque assay by immuno-
staining for better observation (Fig. 5B). To conﬁrm the obvious
discrepancy in plaque formation, a quantiﬁcation experiment by
released crystal violet stain revealed that most mutants and the
wild type caused death of about 70% of cells at 8 or 9 days p.i.,
while M3 and M4 gave about 40% and M8 only 10% or less
(Fig. 5C). This difference in viral cytopathic effect was also
validated in MTT assay by measuring SDH release from cells into
the culture supernatant (Fig. 5D).
sgRNA production is indispensable in DENV-2-induced apoptosis
pathway
Since there was signiﬁcant contrast of cytopathic effect during
virus infection, we further evaluated the apoptosis rate of infected
cells at 4 days p.i. at an MOI of 1. In the ﬂow cytometry assay,
approximately 50% of BHK-21 cells underwent apoptosis in the wild
type and other mutants with the exception of M8 (Fig. 6A).
The mutant M8 could not induce apoptosis in the infected BHK-
21 cells at various multiplicities of infection (data not shown). To
explore the possible mechanism responsible for the DENV-2
Fig. 1. Accumulation of subgenomic RNA in DENV-2-infected cells. (A) Subgenomic RNA production in Vero cells. The mammalian cell line Vero was infected with DENV-2 at
a multiplicity of infection (MOI) of 1. At 72 h p.i., total RNAs were isolated and analyzed by Northern blotting. Lane Vero, DENV-2 infected Vero cells. Lane DENV-2, DENV-2
mature virions. Lane MOCK, uninfected Vero cells. Size markers are indicated on the right. Bands corresponding to the DENV-2 genome and subgenomic RNA are indicated by
arrows. (B) Northern blot of RNAs isolated from BHK-21 cells electroporated with DENV-2 nonreplicating replicon RNA containing the GDD motif of the RNA dependent RNA
polymerase NS5 by AAA, pSUPER-3′ UTR vector, or DENV-2 wild type replicon RNA. Bands corresponding to the DENV-2 replicon genome and subgenomic RNA are indicated
by arrows. (C) Primer extension analysis using 5′-biotinylated oligonucleotide, which is complementary to DENV-2 nt 10,360 to nt 10,384. pACYC TSV repliconwas sequenced
with the same oligonucleotide to obtain a sequencing ladder for determination of the 5′ end of the subgenomic RNA. At least three independent experiments were
performed.
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induced apoptotic pathway, we analyzed caspase-3 and Poly ADP-
ribose polymerase (PARP) cleavage by Western blotting. Caspase-3
is one of the key executors of apoptosis, and its activation leads to
downstream cleavage of PARP. Using the antibody to recognize the
endogenous levels of full-length caspase-3 (35 kD) and the large
fragment of caspase-3 (17 kD) resulting from cleavage we found
Fig. 2. Kinetics of genomic and subgenomic RNA synthesis in DENV-2-infected mammalian cells. (A) Northern analysis of total RNAs isolated from DENV-2-infected Vero
cells at indicated time points post infection. Cells were infected with DENV-2 at an MOI of 0.5. (B) Total RNAs from DENV-2-infected BHK-21 cells were analyzed by Northern
blotting using DIG-labeled oligonucleotide, complementary to nt 10,622 to nt 10,723 in the DENV-2 3′ UTR as a probe. Cells were infected with DENV-2 at an MOI of 0.5.
At least three independent experiments were performed.
Fig. 3. Structure/sequence required for the production of subgenomic RNA. (A) RNA structure model of DENV-2 3′ UTR generated from previously described (Proutski et al.,
1997). TL1/2, top loop of hairpins; (R) CS1/2, (repeated) conserved sequence; 3′-LSH, 3′ long stable hairpin structure. (B) Schematic representation of the DENV-2 genome
organization, 3′ UTR and introduced deletions. Subgenomic RNA 5′ end at position-429 is indicated. (C) Northern blot of RNAs isolated from BHK-21 cells infected with
recombinant viruses. The relative intensities of the subgenomic RNA bands were calculated by using the band intensity of wild type genome RNA for each group as the
denominator and are indicated for each lane. The asterisks indicate that the differences are statistically signiﬁcant (n, Po0.05; nn, Po0.001). The data shown represented the
mean values and standard deviations of the results. Three independent experiments, repeated three times for each sample, were performed.
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Fig. 4. Subgenomic RNA is not essential for DENV-2 life cycle. (A) BHK-21 cells were electroporated with equal amounts (10 μg) of WT, M1–M7, or M8 mutant replicon RNAs.
The transfected cells were harvested at the indicated time points post transfection and Renilla luciferase activities (RLU) were measured. Each data point is a log10 value of the average
of luciferase signals from three independent experiments; the error bars indicate standard deviations. (B) and (C) Luciferase activities were measured separately at 6 h and 60 h post
transfection (BHK-21 cells). The data represented here were obtained from 4A. (D) BHK-21 cells were infected with equal MOI of WT or M1 to M8 mutant viruses. The infected cells
were monitored for viral E protein expression by immunoﬂuorescence assay at 96 h p.i. Anti-E monoclonal antibody 4G2 and Texas Red goat anti-mouse IgG were used as primary and
secondary antibodies, respectively. Representative microscope images were presented. (E) Viral growth kinetics of DENV-2 wild type and the M1 to M8 mutants in BHK-21 cells. BHK-
21 cells were infected at anMOI of 1, and themedium of infected cells was sampled at indicated times post infection. Titers were determined by plaque assays on BHK-21 cells with 1%
crystal violet stained for M1, M2, M5–M7 and with immunoperoxidase staining for M3, M4 and M8. The data represented three independent experiments performed in duplicate.
that mutants M1–M7 and WT could cause caspase-3 cleavage but
not mutant M8 (Fig. 6B). Also, caspase-3 activation ﬁnally resulted
in cleavage of PARP [full-length PARP (116 kD) and the C-terminal
catalytic domain (89 kD)] (Fig. 6C). These data suggested that sgRNA
may play an important role in the DENV-2 induced apoptotic
pathway in a caspase-3-dependent manner.
Fig. 5. Subgenomic RNA is required for viral cytopathicity in cell culture. (A) Plaque morphology of DENV-2 wild type and recombinant viruses by speciﬁc infectivity assay.
(B) Plaque morphology of DENV-2 wild type and M3, M4, M8 recombinant viruses using immunoperoxidase staining. (C) Vero and BHK-21 cells were infected at an MOI of
0.1 with DENV-2 wild type and mutant M1 to M8 viruses and ﬁxed at indicated time points after infection. Crystal violet was released from cells by methanol and OD 620 nm
was measured. Average results and standard deviations from three independent experiments were presented. The left, Vero cells; the right, BHK-21 cells. NC, negative control.
(D) MTT assays. SDH release into cell culture ﬂuid of Vero and BHK-21 cells was measured. Cells were infected with DENV-2 wild type and mutant M1 to M8 viruses at an MOI of
0.1. Average results and standard deviations from three independent experiments were presented. The left, Vero cells; the right, BHK-21 cells. Mock, negative control.
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To better understand different apoptotic signaling pathways
between M8 andWT, we examined this in more detail. To compare
the viral replication level, we extracted total cellular RNAs from
the M8 and WT infected cells; the viral RNA amounts were
quantiﬁed using one-step real-time RT-PCR. Meanwhile, structural
protein E and nonstructural protein NS1 were also quantiﬁed using
Western blotting throughout the experimental period. The stan-
dard curve obtained from known input copies was determined
(data not shown). From Fig. 6D, the genomic RNA of M8 mutant in
infected BHK-21 cells was as much as that of WT for the ﬁrst 24 h
p.i. In the remaining experimental time, the accumulation of the
M8 genome followed the same trend as the wild type genome but
statistical analysis showed that at 36 h p.i. the amount was less
by three to four times. The expression levels of protein E and NS1
in both M8 and wild type infected cells were approximately equal
(Fig. 6E).
To deﬁne the pathway by which sgRNA leads to apoptosis,
we examined the activation of phosphatidylinositol 3-kinase/Akt
signaling in the DENV-2-infected BHK-21 cells. The phosphorylation
status of Akt was monitored by Western blot using an antibody
speciﬁc to phosphor-Akt (ser473). Cells infected with wild type and
M8 at an MOI of 1 were lysed at various time points post infection.
The amounts of phosphorylated Akt were plentiful in wild type and
M8 infected cells around 12 h to 24 h post infection (Fig. 6E). At the
later stages the protein levels of phosphorylated Akt in the wild
type were found to be reduced gradually but not in the M8 mutant.
These results suggested that both the wild type and M8 could
activate Akt phosphorylation after virus infection and that Akt
phosphorylation level was maintained for longer in M8-infected
cells than in the wild type.
Subsequently, we used an antibody speciﬁc to the bcl-2 protein
and we found the expression level of bcl-2 between the WT and
mutant M8 was different. Cells infected with WT and M8 at an
MOI of 1 were lysed at indicated times post infection. As shown in
Fig. 6E, the bcl-2 protein was evident in the wild type starting from
12 h to 36 h p.i. but later its amount began to decrease to a much
lower level. In contrast, the bcl-2 protein in M8-infected cells
maintained a high expression level throughout infection.
Complementation experiment with sgRNA
To conﬁrm the role of sgRNA in virus-induced cytopathicity and
apoptosis, the defect in sgRNA production was complemented by
providing sgRNA in trans from transfected vector pSUPER-sgRNA.
The cytopathicity and apoptosis of M8 were partially restored in
sgRNA-existing cells. In cells producing sgRNA the M8 mutant can
form visible plaques (Fig. 7A), and also the cytopathic effect with
released crystal violet stain (Fig. 7B) and the apoptotic rate were
signiﬁcantly increased (Fig. 7C). Due to a transfection efﬁciency of
about 50%, the compensation was limited. In addition, sgRNA
alone could not induce cell death or even apoptosis, indicating
that sgRNA must act under the condition of viral infection to
promote virus-induced cytopathicity and apoptosis.
Discussion
Recent work has demonstrated that members of the Flavivirus
genus can produce abundant, subgenomic, noncoding RNA derived
from the 3′ untranslated region of genome RNA (Pijlman et al.,
2008). In this study, we have identiﬁed cells infected with DENV-2
(TSV01 strain) that generate a RNA species. This subgenomic
noncoding RNA is of viral origin and not packaged into mature
virions. Viral proteins, RNA replication or even 5′ UTR is not
Fig. 6. Subgenomic RNA requirement for apoptosis pathway. (A) Apoptosis assays. BHK-21 cells were infected with DENV-2 wild type and mutant M1 to M8 viruses at an
MOI of 1. After 96 h post infection, the cells were collected and analyzed by ﬂow cytometry using Annexin V-FITC/PI staining. Representative data of three independent
experiments are shown here. (B) and (C) Caspase-3 (B) and PARP (C) cleavage in infected cells. BHK-21 cells were infected with DENV-2 wild type and mutant M1 to M8
viruses at an MOI of 1 and were lysed at 96 h p.i. Western blotting was performed with the antibodies for caspase-3 (B), PARP (C), and GAPDH. NC, negative control. At least
three independent experiments were performed. (D) Kinetics of the M8 mutant and wild type genome RNA synthesis in infected BHK-21 cells. The cells were infected at an
MOI of 1, and extracted RNA were subjected to real-time RT-PCR assay. Average results and standard deviations from three independent experiments were presented.
(E) Kinetics of protein Akt phosphorylation, Bcl-2, envelope E and NS1 expression level in DENV-2 wild type and M8 mutant. BHK-21 cells were infected at an MOI of 1 and
then the cells were cultured for various periods (in hours) as indicated at the top. The cell lysates were harvested for Western blot analysis with the speciﬁc antibodies for
Ser473-phospho-Akt, Bcl-2, E, NS1 and GAPDH. NC, negative control. At least three independent experiments were performed.
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responsible for its production (Fig. 1). Thereby, some cellular
proteins or factors are possibly involved in sgRNA biogenesis. A
previous study indicated that the host exoribonuclease XRN1
hydrolyzed the viral genome in a 5′–3′ direction yielding sgRNA
(Silva et al., 2010). In our study, genetic analysis using DENV-2 full-
length infectious clones and recombinant viruses revealed that
conserved structures in the viral 3′ UTR are crucial for the produc-
tion of full-length sgRNA. Combined with Northern blot, each
deletion in structure X, region I, TL1, RCS2, TL2 or CS2 did not cause
the loss of sgRNA except for deletions in region II (Fig. 3). Thus we
conclude that the sequence in region II in 3′ UTR may act as a signal
to XRN1. Since the separate deletion of TL1 and RCS2, both located in
region II, reduced the amount of sgRNA, the sequence in region II
including these two structures seems to be more important,
suggesting that some tertiary interactions, particularly pseudoknot
interactions, may be also required in the production of nuclease-
resistant sgRNA.
It is still unclear why sgRNA is generated in a Dengue-2 virus
infection. Corresponding studies in WNV has identiﬁed two
functions of sgRNA that contribute to viral evasion of the type I
Fig. 7. Partial rescue of virus-induced cytopathicity and apoptosis by complementation with subgenomic RNA. (A) Viral plaque formation by sgRNA complementation.
BHK-21 cells were transfected with pSUPER-sgRNA. After 24 h cells were infected with recombinant M8 virus, overlaid and stained at 5 days p.i. (B) Partial rescue of virus-
induced cytopathicity. BHK-21 cells were transfected with subgenomic RNA-producing plasmid pSUPER-sgRNA. At 24 h post transfection, cells were infected with mutant M8
at an MOI of 0.1. Cells infected with wild type or untreated were used as controls. At 8 days post infection, crystal violet released from cells by methanol was measured at OD
620 nm. NC, negative control. The asterisks indicate that the differences are statistically signiﬁcant (n, Po0.05; nn, Po0.001). The data shown represented the mean values
and standard deviations of the results. Three independent experiments, repeated three times for each sample, were performed. (C) Partial rescue of virus-induced apoptosis.
BHK-21 cells were transfected with subgenomic RNA-producing plasmid pSUPER-sgRNA. At 24 h post transfection, cells were infected with mutant M8 at an MOI of 1. Cells
infected with wild type or untreated were used as controls. Apoptosis assays were performed at 96 h p.i. NC, negative control. Representative data of three independent
experiments were shown here.
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interferon response and display RNA interference suppressor
activity (Schnettler et al., 2012; Schuessler et al., 2012). Growing
evidence indicates that sgRNA probably plays a role in modulating
the host antiviral response via RNA-mediated pathways. Our result
suggests that sgRNA may indeed act during virus–host interplay.
We have shown that the ability to produce abundant full-length
sgRNA is required for virus-induced cytopathicity in cell culture
and apoptotic cell death. Interestingly, sgRNA alone without
Dengue-2 virus infection did not induce cell death, while it can
partially rescue the cytopathicity and also apoptosis of mutant
virus defective in sgRNA generation (Fig. 7). It demonstrates that
sgRNA must interact with virus in host cells. Therefore we propose
that sgRNA might be a viral signaling factor in a DENV-2-induced
apoptosis pathway. Additionally, no matter what the origin of
sgRNA was, it was always functioning during a Dengue-2 virus
infection (Fig. S2). This result suggests that sgRNA may not have
species speciﬁcity.
To date, cell death caused by ﬂavivirus infection has been
associated via several pathways and mechanisms, including necro-
sis and apoptosis (Ait-Goughoulte et al., 2008; Medigeshi et al.,
2007; Ramanathan et al., 2006; Su et al., 2002; Yang et al., 2002).
Whether in vitro or in vivo, apoptosis has been implicated as a
cytopathologic mechanism in response to Dengue virus infection
in various cell types (Courageot et al., 2003). Our ﬁndings clarify
that the wild type of DENV-2 can induce apoptosis in BHK-21 cells
while the mutant virus deﬁcient in sgRNA generation cannot. It is
possible the production of sgRNA contributed to the induction of
apoptotic cell death after infection. The apoptosis pathway by
Dengue-2 virus infection is in a caspase-3 dependent manner, and
ﬁnally results in the cleavage of PARP.
How does sgRNA lead to apoptotic cell death of Dengue-2 virus
infection? Recently accumulated evidence proves that viruses can
modulate the PI3K/Akt signaling pathways, and some earlier studies
indicates the pathway serves an anti-apoptotic role (Cooray, 2004;
Lee et al., 2005). The probability that the PI3k/Akt pathway
participates in host cell survival during viral infection has prompted
us to investigate the relation between sgRNA and this transduction
pathway. Analysis from the Western blotting (Fig. 6) shows that
Akt can be phosphorylated after wild type and M8 virus infection;
however, the wild type level of Akt phosphorylation decreased at
48 h after infection, while in M8 virus it maintained a constant level,
which might then protect cells from apoptosis. Because bcl-2 is one
of the major downstream mediators of the PI3k/Akt pathway, the
expression of bcl-2 protein was also detected. In wild type and M8
mutant virus the trend of bcl-2 were almost the same as that of the
phosphorylated Akt. The protein bcl-2 remained at a high level in
M8 virus infected cells, and in wild type it began to reduce at 72 h
after infection. Considering the time course, the wild type virus just
started apoptosis at 72 h p.i., a later stage of infection (Fig. S1). The
accordance between these two proteins rules out that Dengue-2
virus infection initiates at least two pathways: apoptosis transduc-
tion to kill the infected cells and survival signaling to hold cells in a
status amenable to longer virus progeny production. The sgRNA cells
did not sustain the protein levels of phosphorylated Akt at the later
time points after virus infection, so the downstream factor bcl-2
subsided and ﬁnally the cells underwent apoptosis. Without the
sgRNA, cells could hold the level of Akt phosphorylation at a
constant level and then up-regulate the bcl-2 protein, and the cells
survived. Since sgRNA was also aggregated at the later time points
after virus infection, it is indeed of signiﬁcance in inhibiting PI3K/Akt
signaling pathway, and inevitably eliminated the infected cells.
In summary, sgRNA is a determinant in Dengue-2 virus-induced
apoptosis and is possibly involved in PI3k/Akt signaling pathway
through a Bcl-2-related mechanism, resulting in apoptotic cell death.
The data represented here exhibit a novel function of sgRNA in
virus-induced apoptotic cell death. Dengue-2 virus has evolved a
RNA species to interact with the host cells to balance the apoptotic
and antiapoptotic signaling pathway. Whether or not the sgRNA is
involved in the interplay between the host cell and the virus decides
the outcome of Dengue-2 virus infection. Our study provides useful
insight into dengue virus infection and deﬁnes a novel function in
virus noncoding RNA. Thereafter the experimental result may be
applicable to other serotypes of Dengue viruses. Moreover, the virus
deﬁcient in production of sgRNA possesses high potentiality for the
development of a Dengue-2 virus attenuated vaccine.
Materials and methods
Cells and viruses
Baby hamster kidney (BHK-21) cells and African green monkey
kidney (Vero) cells were cultured in Dulbecco's modiﬁed Eagle
medium (DMEM; Gibco) supplemented with 10% fetal bovine serum
(FBS; Gibco) and 1% penicillin/streptomycin in 5% CO2 at 37 1C.
DENV-2 was prepared from a full-length infectious cDNA clone
(pACYC TSVFL; strain TSVO1).
Construction of plasmids
Recombinant plasmids were constructed by using an infectious
cDNA clone of DENV-2 (pACYC TSVFL; strain TSV01) and a cDNA clone
of a Renilla luciferase replicon of DENV-2 (pACYC TSV replicon; strain
TSV01) (Zou et al., 2011). The mutated DNA fragments were pasted
back into the pACYC TSVFL at the NruI and ClaI sites (nucleotide
positions 7735 and 10,921, respectively) and the pACYC TSV replicon
at the XbaI and ClaI sites (nucleotide positions 4908 and 9827,
respectively). The primer pairs used for mutagenesis are listed in
Table 1. All constructs were veriﬁed by DNA sequencing.
RNA preparation and northern blot analysis
Total RNA from the DENV-2-infected cells was extracted with
Trizol reagent (Invitrogen) following the manufacturer's instruc-
tions. Cytoplasmic/Nuclear RNA was isolated and puriﬁed by using
Cytoplasmic & Nuclear RNA Puriﬁcation Kit (Norgen). RNAs were
quantiﬁed using a NanoDrop spectrophotometer (NanoDrop).
About 10 μg of RNA was subjected to denaturing gel electrophor-
esis in 1.5% agarose and 2% formaldehyde, followed by transfer
Table 1
Primers for mutagenesisa.
Primer name Sequence (5′ to 3′)
NS5Mut_F AGTGCAGCTGCTTGTGTTGTGAAACCCTTAGATG
NS5Mut_R CATCTAAGGGTTTCACAACACAAGCAGCTGCACT
M1_F GCAGGAGTCTTGTGGTAGAAGTCAGAAGTCAGGTCG
M1_R CGACCTGACTTCTGACTTCTACCACAAGACTCCTGC
M2_F AGGAACATCATGAGACAACCGTCCAAGGACGTTAAA
M2_R TTTAACGTCCTTGGACGGTTGTCTCATGATGTTCCT
M3_F GGGAGGCCACAAACCATGCGCATGGCGTAGTGGACT
M3_R AGTCCACTACGCCATGCGCATGGTTTGTGGCCTCCC
M4_F TGTACGCATGGCGTAGTGCTCCCTTACAAATCGCAG
M4_R CTGCGATTTGTAAGGGAGCACTACGCCATGCGTACA
M5_F GGGGGCCCAAGGTGAGATGTCTCACTGAAAGGACTA
M5_R TAGTCCTTTCAGTGAGACATCTCACCTTGGGCCCCC
M6_F CTGTAGTCTCACTGAAAGCCCCGAAATAAAAAACAG
M6_R CTGTTTTTTATTTCGGGGCTTTCAGTGAGACTACAG
M7_F AGCCCCGTCCAAGGACGTAAATCTGGGAGGCCACAA
M7_R TTGTGGCCTCCCAGATTTACGTCCTTGGACGGGGCT
M8_F CACCTGAGAAGGTGTAAAAACAGCATATTGACGCTG
M8_R CAGCGTCAATATGCTGTTTTTACACCTTCTCAGGTG
a A pair of forward (F) and reverse (R) primers was used to generate mutant
replicon and genome length RNAs.
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onto Hybond-N membranes (Amersham). Hybridization and
visualization were performed using the DIG Northern Starter Kit
(Roche).
Primer extension assay
Primer extension analysis was performed as described by
Sanbrook et al. (1989). Brieﬂy, total RNA from DENV-2 infected
cells was annealed to 5′-biotinylated oligonucleotide which is
complementary to DENV-2 nt 10,360 to nt 10,385. Then primer
extension reactions were performed using Moloney Murine
Leukemia Virus reverse transcriptase (Invitrogen). The products
were analyzed in a denaturing 8% polyacrylamide-8M urea
sequencing gel. The pACYC TSVFL as a template was run in the
same gel to serve as a size and sequence marker.
Transient replicon assay
A transient DENV-2 replicon assay was used to quantify viral
translation and RNA replication. BHK-21 cells were electroporated
with 10 μg of replicon RNA using a GenePulser Xcell system (Bio-
Rad) and an established protocol (Falgout et al., 1993). The trans-
fected cells were re-suspended in 25 ml of DMEM with 10% FBS,
seeded into 12-well plates (1 ml/well), and assayed for luciferase
activities at the indicated time points.
In vitro transcription, RNA transfection, speciﬁc infectivity assay (SIA),
and immunoﬂuorescence assay (IFA)
Both genome-length and replicon RNAs of DENV-2 were in vitro
transcribed from corresponding cDNA plasmids that were linearized
with ClaI. A T7 mMessage mMachine kit (Ambion) was used for RNA
synthesis as described previously (Falgout et al., 1993). The RNA
transcripts were electroporated into BHK-21 cells and culture ﬂuids
were harvested, aliquoted and stored at 80 1C (Zou et al., 2011).
For speciﬁc infectivity assay (SIA), 1 ml of a series of 1:10 dilutions of
the transfected cells were seeded onto conﬂuent BHK-21 cell
monolayers (6105 cells per well seeded in a six-well plate 2 days
in advance). The seeded cells were allowed to attach to the plates for
5 h before addition of 3 ml DMEM containing 1.2% methyl cellulose
(Aquacide II; Calbiochem) and 2% FBS. After 5 days of incubation at
37 1C with 5% CO2, the cells were ﬁxed in 3.7% formaldehyde (Sigma)
and stained with 1% crystal violet. An immunoﬂuorescence assay
(IFA) was performed as described previously (Shi et al., 2002), using
anti-E monoclonal antibody 4G2 and Texas Red goat anti-mouse IgG
as primary and secondary antibodies, respectively.
Plaque assay and growth kinetics
For plaque assays, BHK-21 cells in 12-well plates were infected
with a dilution series of viruses. Cells were overlaid with 1.2%
methyl cellulose in DMEM containing 2% FBS, incubated at 37 1C
for 3 to 4 days, ﬁxed with 3.7% formaldehyde and with 1% crystal
violet stained or with immunoperoxidase staining. BHK-21 cells
were infected at a multiplicity (MOI) of 1 for 1 h at 37 1C, washed
three times with PBS and overlaid with DMEM containing 2% FBS.
For growth curves, cell culture ﬂuid from 6-well plates was
harvested at the indicated times post infection to determine virus
titers by standard plaque assay.
Real-time quantitative PCR analysis
For quantitative PCR, RNA samples were performed with a
One Step SYBR PrimeScript Plus RT-PCR Kit (TAKARA). The cycling
conditions were as follows: an initial hold at 95 1C for 1 min,
followed by 40 cycles consisting of 94 1C for 15 s, and 60 1C for
30 s. The primers used for RT Q-PCR were as follows: ACAGTCTG-
GAACAGGGTGTGGATT and TTGTTAGCCCAATCAATGAGCCGC. The
product was 133 nucleotides in length.
Cytotoxicity assay
Vero and BHK-21 cells were seeded into 96-well plates and
infected with MOI¼0.1. At 3 to 8 days after infection, CPE was
assessed as described previously (Liu et al., 2006). SDH release
from cells was measured with MTT Cell Proliferation and Cyto-
toxicity Assay Kit (Beyotime) according to the manufacturer's
instruction.
Complementation analysis
For complementation of a subgenomic RNA deﬁciency mutant,
the fragment of subgenomic nucleotides was inserted into the
plasmid pSUPER. Primers for PCR were as follows: CGCGGATCCC-
CAAGTCAGAAGTCAGGTCGGA and CCCAAGCTTAAAAAAGAACCTGTT-
GATTCAACAG. To complement sgRNA, BHK-21 cells plated at a
density of about 50% were transfected with 500 ng pSUPER-sgRNA
and control pSUPER. At 24 h after transfection, cells were infected
with the mutant virus.
Apoptosis assay
Apoptosis was assayed by Annexin V-FITC/PI staining following
the manufacturer's protocol (Bender MedSystems). Brieﬂy, after
96 h or 120 h of infection, the cells were collected and washed in
cold PBS. Then the harvested cells were resuspended in 200 μl
1 binding buffer, Annexin V-FITC (1 ) and PI (5 μg/ml) were
added to the cells followed by incubation at room temperature in
the dark for 10 min. After incubation, 200 μl of 1 binding buffer
was added to each sample, and cells were analyzed by ﬂow
cytometry (Beckman Coulter EpicsXL).
Antibody and Western blot analysis
Monoclonal antibodies including caspase-3 (#9662), PARP
(#9542), bcl-2 (#2876) and phosphor-Akt (Ser473) (#9271) were
purchased from Cell Signaling Technology Inc. Monoclonal anti-
GAPDH (60004-1-Ig) antibody was purchased from Proteintech Inc.
The antiserum of NS1 was stored in our laboratory. For immunoblot
analysis, the cells were lysed by cell lysis buffer for Western and IP
(Beyotime). Cell lysates were mixed with loading buffer (with
β-mercaptoethanol), separated by SDS-PAGE, and transferred to a
nitrocellulose membrane (Amersham). The blots were developed
with an ECL system (Bio-Rad).
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